
|Articles|October 15, 2016
- BioPharm International-10-15-2016
- Volume 2016 eBook
- Issue 2
Plant-Made Pharmaceuticals—Accelerating Drug Development Globally
Author(s)Barry Holtz
Plant transient expression offers a flexible approach in drug development and enables rapid production and scale up of therapeutics.
Advertisement
Plant transient expression offers a flexible approach in drug development and enables rapid production and scale up of therapeutics.
Download the BioPharm International
.
Articles in this issue
over 9 years ago
Cell Line Quality Technologiesover 9 years ago
Investigation Effectiveness Drives Human Performance Excellenceover 9 years ago
Data Integrity Challenges in Manufacturingover 9 years ago
Seeking Accelerated Biosimilar Characterizationover 9 years ago
Testing the BrothNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
2
Bio/pharma Manufacturing Professionals Are Staying Put Despite Growing Uncertainty
3
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
4
Green Chemistry’s Role in Advancing US Chemical Innovation
5





